Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
RCKT, RCKTW | ROCKET PHARMACEUTICALS, INC. | Chief Medical & Gene Therapy Officer | $4.31M | -$224K | -4.94% | Feb 11, 2025 |
TRHC | Tabula Rasa HealthCare, Inc. | Director | Nov 3, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|